Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker

1 Jul 2018

Abstract excerpt

BACKGROUND/AIM: Exosomes, derived from chronic myelogenous leukaemia (CML) cells, can be used as biomarkers and new targets for the detection of the BCR-ABL transcript. This study aimed to identify these possibilities. MATERIALS AND METHODS: Human CML cell line-derived exosomes and CML-patients-derived exosomes were isolated with a size-exclusion chromatography column and ExoQuick™ exosome precipitation solution,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes
Share to Extracellular vesicles in disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29970515
DOI: 10.21873/anticanres.12679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a BiomarkerPMID 29970515Read ↗

Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemiaSemantic proximity Read ↗

Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.Semantic proximity Read ↗

Exosomes as a promising tool for research and molecular diagnostics of myeloproliferative disordersSemantic proximity Read ↗

Selective miRNA Expression Profile in Chronic Myeloid Leukemia K562 Cell-derived ExosomesSemantic proximity Read ↗

Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid LeukemiaSemantic proximity Read ↗

Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in LeukemogenesisSemantic proximity Read ↗

Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disordersSemantic proximity Read ↗

S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progressionSemantic proximity Read ↗

Exosomal miRNA expression profiling in patients with imatinib resistant Chronic myeloid leukemia: A pilot studySemantic proximity Read ↗

Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365Semantic proximity Read ↗

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndromeSemantic proximity Read ↗

Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinibSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.